|

BTM-3566 Clinical Trials

2 actively recruiting trials across 2 locations

No change since June 2026

Also known as: BTM-3566 Oral Solution

Pipeline

Phase 1: 2

Top Sponsors

  • Bantam Pharmaceuticals2

Indications

  • Cancer2
  • Lymphoma, B-Cell1
  • Advanced Solid Tumors1

Charlotte, North Carolina1 trial

Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

Levine Cancer Institute, Atrium Health

Phase 1

Houston, Texas1 trial

BTM-3566 in Advanced Solid Tumors

NEXT Houston

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.